M. Wong et al., EVIDENCE FOR RANTES, MONOCYTE CHEMOTACTIC PROTEIN-1, AND MACROPHAGE INFLAMMATORY PROTEIN-1-BETA EXPRESSION IN KAWASAKI-DISEASE, Journal of rheumatology, 24(6), 1997, pp. 1179-1185
Objective, Patients with Kawasaki disease mount an immune response dir
ected to their abnormally stimulated vascular endothelium, that is ass
ociated with vascular inflammation and injury and a predisposition to
arterial aneurysm formation. This suggests that specific pro-inflammat
ory cytokines may mediate these hyperreactive responses. The selective
chemoattractant and activation effects of chemokines on lymphocytes i
dentifies them as potential candidates in mediating selective inflamma
tory processes in Kawasaki disease. We examined peripheral blood from
patients with Kawasaki disease for chemokine gene expression. Methods.
Consecutive samples from 14 patients during the acute, subacute, and
convalescent phases of their illness were collected and elaborated for
RANTES, macrophage inflammatory protein-1 beta (MIP-1 beta) and monoc
yte chemotactic protein-1 (MCP-1) expression. Results. RANTES and MCP-
1 gene expression levels were significantly elevated in 12 of the 14 p
atients, and MIP-1 beta gene expression was elevated in 13 of the 14 p
atients. There was no obvious correlation between clinical phase of th
e disease and chemokine expression level, yet elevated expression leve
ls were detected in all phases, including the convalescent phase, when
laboratory evidence of lymphocyte activation has been shown to return
to normal, Serial samples showed persistence or increased expression
of chemokine genes into the convalescent phase in patients with corona
ry artery lesions. Conclusion, Chemokine mediated inflammatory events
may persist in the convalescent phase of. Kawasaki disease and may con
tribute to further risk of vascular endothelial cell injury, specifica
lly coronary aneurysm formation.